Sugi Predict

Sugi Predict / Compounds / SCHEMBL15534273

SCHEMBL15534273

SCHEMBL15534273

O=S(=O)(O)c1[c]c2c(cc1)ccc1cc3ccccc3cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ CYP2D6 P10635 1/20 0.35
▸ MPL P40238 3/20 0.35
▸ CTRC Q99895 2/20 0.35
▸ HSD17B10 Q99714 5/20 0.34
▸ HIF1A Q16665 3/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ CYP2C19 P33261 4/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ SNCA P37840 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CTRB1 P17538 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2C9 P11712 3/20 0.32
▸ CASP6 P55212 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6634238 0.78 TTR (0.37) MPLCTRCCYP1A2CTRB1ATIC
SCHEMBL17707249 0.78 SNCA (0.36) ALDH1A1CYP2D6MPLCTRCHSD17B10
SCHEMBL483064 0.72 SMN1; SMN2 (0.37) ALDH1A1KDM4ECYP2D6MPLCTRC
SCHEMBL30108870 0.70 CYP2D6 (0.46) ALDH1A1KDM4EGAACYP2D6MPL
SCHEMBL151653 0.70 CYP2D6 (0.46) ALDH1A1KDM4EGAACYP2D6MPL
SCHEMBL10388421 0.70 CYP2A6 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL7622546 0.70 ALDH1A1 (0.40) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL10388990 0.70 ALDH1A1 (0.40) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL29623319 0.70 TTR (0.50) ALDH1A1KDM4EGAACYP2D6MPL
SCHEMBL155232 0.70 TTR (0.50) ALDH1A1KDM4EGAACYP2D6MPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190070305-A1 BENZODIAZEPINES AND CONJUGATES THEREOF IMMUNOGEN, INC. 2019-03-07 — — US disclosed
US-20170274091-A1 BENZODIAZEPINES AND CONJUGATES THEREOF IMMUNOGEN, INC. 2017-09-28 — — US disclosed
US-9555125-B2 Benzodiazepines and conjugates thereof IMMUNOGEN, INC. (US) 2017-01-31 — — US disclosed
US-20150209444-A1 BENZODIAZEPINES AND CONJUGATES THEREOF IMMUNOGEN, INC. (US) 2015-07-30 — — US disclosed
WO-2013177481-A1 BENZODIAZEPINES AND CONJUGATES THEREOF IMMUNOGEN, INC. (US) 2013-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209444-A1 BENZODIAZEPINES AND CONJUGATES THEREOF GABBR1, GABRA1, GABBR2 ALDH1A1 246/4885KDM4E 3124/4885GAA 1931/4885
US-20170274091-A1 BENZODIAZEPINES AND CONJUGATES THEREOF GABBR1, GABRA1, GABBR2 ALDH1A1 246/4885KDM4E 3124/4885GAA 1931/4885
US-20190070305-A1 BENZODIAZEPINES AND CONJUGATES THEREOF GABBR1, GABRA1, GABBR2 ALDH1A1 246/4885KDM4E 3124/4885GAA 1931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.